does semaglutide cause kidney damage cuts risk in obesity | Journal of Endocrinological Investigation Ozempic (semaglutide) is a prescription

Work with your healthcare provider to adjust meal-time insulin doses and timing when starting or adjusting a GLP-1 agonist

Both versions of the drug have similar safety profiles but come with a relatively high proportion of patients reporting side effects like nausea and constipation

Several reasons may explain the observation that the mean treatment difference was 12.5% in STEP 1 and 8.7% in SELECT

A consistent, well-tolerated single-medication protocol may produce better cumulative results over years than a cycling approach that maximizes short-term weight loss at the cost of repeated adjustment periods

MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation